ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,983,000 | -66.5% | 366,626 | -81.6% | 0.45% | -63.8% |
| Q1 2017 | $17,843,000 | -2.1% | 1,995,880 | -3.8% | 1.24% | -1.1% |
| Q4 2016 | $18,227,000 | +111.4% | 2,073,680 | +62.4% | 1.26% | +102.6% |
| Q3 2016 | $8,621,000 | +865.4% | 1,277,214 | +503.3% | 0.62% | +870.3% |
| Q4 2015 | $893,000 | -91.6% | 211,714 | -85.4% | 0.06% | -91.3% |
| Q1 2015 | $10,687,000 | – | 1,450,173 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |